Drug intelligence / Profile preview

pre-miR-125a-5p mimic

Development stage
Preclinical
Lead developer
CINVESTAV
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

pre-miR-125a-5p mimic is a synthetic, double-stranded RNA molecule designed to replicate the biological activity of the endogenous tumor suppressor microRNA, miR-125a-5p. In various malignancies, including cervical carcinoma, miR-125a-5p expression is frequently downregulated, which facilitates tumor progression. By introducing this mimic, researchers can restore miR-125a-5p levels, which subsequently binds to the 3' untranslated regions (UTRs) of specific target mRNAs such as MARK1 (Microtubule Affinity Regulating Kinase 1) and VEGF (Vascular Endothelial Growth Factor). This binding leads to mRNA degradation or translational repression, effectively downregulating these proteins and resulting in cell-cycle arrest, inhibition of proliferation, and the induction of apoptosis. It is primarily utilized as a research tool to investigate miRNA-mediated gene regulation and potential therapeutic strategies in oncology.

Brand names
Pre-miR
Other names
miR-125a-5p mimicmiR125a-5p mimicmiR 125a-5p mimichsa-miR-125a-5p mimichsa-miR125a-5p mimichsa-miR 125a-5p mimic
02

Targets

MARK1 (Microtubule affinity regulating kinase 1)BCL-2 (BCL-2 family)Vascular endothelial growth factor A messenger RNA 3′ untranslated region

Beyond the preview

Go deeper on pre-miR-125a-5p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pre-miR-125a-5p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call